- Home
- NVCT vs FINW Comparison
NVCT vs FINW Comparison
Compare NVCT & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- FINW
- Stock Information
- Founded
- NVCT 2020
- FINW 1999
- Country
- NVCT United States
- FINW United States
- Employees
- NVCT N/A
- FINW N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- FINW Commercial Banks
- Sector
- NVCT Health Care
- FINW Finance
- Exchange
- NVCT Nasdaq
- FINW Nasdaq
- Market Cap
- NVCT 184.9M
- FINW 196.2M
- IPO Year
- NVCT 2022
- FINW 2021
- Fundamental
- Price
- NVCT $8.13
- FINW $14.06
- Analyst Decision
- NVCT Strong Buy
- FINW Buy
- Analyst Count
- NVCT 3
- FINW 4
- Target Price
- NVCT $17.00
- FINW $20.75
- AVG Volume (30 Days)
- NVCT 97.5K
- FINW 18.4K
- Earning Date
- NVCT 08-05-2025
- FINW 07-24-2025
- Dividend Yield
- NVCT N/A
- FINW N/A
- EPS Growth
- NVCT N/A
- FINW N/A
- EPS
- NVCT N/A
- FINW 0.91
- Revenue
- NVCT N/A
- FINW $72,056,000.00
- Revenue This Year
- NVCT N/A
- FINW $38.17
- Revenue Next Year
- NVCT N/A
- FINW $18.44
- P/E Ratio
- NVCT N/A
- FINW $15.54
- Revenue Growth
- NVCT N/A
- FINW 7.66
- 52 Week Low
- NVCT $4.44
- FINW $10.10
- 52 Week High
- NVCT $11.80
- FINW $20.94
- Technical
- Relative Strength Index (RSI)
- NVCT 37.24
- FINW 42.63
- Support Level
- NVCT $8.79
- FINW $13.66
- Resistance Level
- NVCT $9.30
- FINW $14.95
- Average True Range (ATR)
- NVCT 0.50
- FINW 0.53
- MACD
- NVCT -0.11
- FINW -0.03
- Stochastic Oscillator
- NVCT 12.43
- FINW 31.25
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.